These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11602712)

  • 1. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
    Aiyar A; Aras S; Washington A; Singh G; Luftig RB
    Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.
    Hodin TL; Najrana T; Yates JL
    J Virol; 2013 Dec; 87(23):13020-8. PubMed ID: 24067969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    Platt TH; Tcherepanova IY; Schildkraut CL
    J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The linking regions of EBNA1 are essential for its support of replication and transcription.
    Mackey D; Sugden B
    Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.
    Schepers A; Ritzi M; Bousset K; Kremmer E; Yates JL; Harwood J; Diffley JF; Hammerschmidt W
    EMBO J; 2001 Aug; 20(16):4588-602. PubMed ID: 11500385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Frappier L; O'Donnell M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10875-9. PubMed ID: 1660154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
    Polonskaya Z; Benham CJ; Hearing J
    Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of minimal oriP of Epstein-Barr virus required for DNA replication.
    Shirakata M; Hirai K
    J Biochem; 1998 Jan; 123(1):175-81. PubMed ID: 9504426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
    Koons MD; Van Scoy S; Hearing J
    J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.